Pharmaceutical composition comprising Aliskiren

Details for Australian Patent Application No. 2010226615 (hide)

Owner Novartis AG

Inventors Bose, Sonali; Li, Shoufeng; Wen, Hong

Agent Davies Collison Cave

Pub. Number AU-A-2010226615

PCT Pub. Number WO2010/107966

Priority 61/161,883 20.03.09 US

Filing date 18 March 2010

Wipo publication date 23 September 2010

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 47/02 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

Event Publications

15 September 2011 PCT application entered the National Phase

  PCT publication WO2010/107966 Priority application(s): WO2010/107966

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010226618-Improved chemical synthesis of diazaindoles by Chichibabin cyclization

2010226613-Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration